Literature DB >> 1520191

Why deliver in the supine position?

G N Allahbadia1, P R Vaidya.   

Abstract

This study was conducted at the Lokmanya Tilak Municipal General Hospital, Bombay, India during the year 1990. The aim was to compare the routinely used supine position versus ambulation in the first stage and squatting position during the second stage of labour. Our study was comprised of 200 patients both primigravidas and multigravidas; 100 were kept in the supine position throughout labour and 100 were kept ambulatory in the first stage and adopted the squatting position during the second stage. The study showed a shortening of both stages of labour in the squatting group but the incidence of complications was less in the control group. It was concluded that without proper birthing chairs which can give excellent perineal support, the usual supine position is preferable in our setup.

Entities:  

Mesh:

Year:  1992        PMID: 1520191     DOI: 10.1111/j.1479-828x.1992.tb01918.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  4 in total

Review 1.  Maternal positions and mobility during first stage labour.

Authors:  Annemarie Lawrence; Lucy Lewis; G Justus Hofmeyr; Therese Dowswell; Cathy Styles
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 2.  Position in the second stage of labour for women without epidural anaesthesia.

Authors:  Janesh K Gupta; Akanksha Sood; G Justus Hofmeyr; Joshua P Vogel
Journal:  Cochrane Database Syst Rev       Date:  2017-05-25

3.  Predictors for health facility delivery in Busia district of Uganda: a cross sectional study.

Authors:  Agnes Anyait; David Mukanga; George Bwire Oundo; Fred Nuwaha
Journal:  BMC Pregnancy Childbirth       Date:  2012-11-20       Impact factor: 3.007

4.  Maternal position during the first stage of labor: a systematic review.

Authors:  João P Souza; Maria A Miquelutti; Jose G Cecatti; Maria Y Makuch
Journal:  Reprod Health       Date:  2006-11-30       Impact factor: 3.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.